PRD, C., J, M., J, S., S, K., M, E., GCM, L., . . . JJ, B. (2024). Guideline implementation, drug sequencing, and quality of care in heart failure: Design and rationale of TITRATE-HF. ESC heart failure, 11(1), 550. https://doi.org/10.1002/ehf2.14604
Chicago Style (17th ed.) CitationPRD, Clephas, et al. "Guideline Implementation, Drug Sequencing, and Quality of Care in Heart Failure: Design and Rationale of TITRATE-HF." ESC Heart Failure 11, no. 1 (2024): 550. https://doi.org/10.1002/ehf2.14604.
MLA (9th ed.) CitationPRD, Clephas, et al. "Guideline Implementation, Drug Sequencing, and Quality of Care in Heart Failure: Design and Rationale of TITRATE-HF." ESC Heart Failure, vol. 11, no. 1, 2024, p. 550, https://doi.org/10.1002/ehf2.14604.
Warning: These citations may not always be 100% accurate.